Pretax income is the income that a company earns before paying income taxes. Mustang Bio's pretax income for the
three
months ended in Dec. 2023 was $-8.62 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-51.60 Mil.
Mustang Bio's pretax margin was %.
Mustang Bio Pre-Tax Income Historical Data
The historical data trend for Mustang Bio's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mustang Bio's Pre-Tax Income
For the Biotechnology subindustry, Mustang Bio's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mustang Bio's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Mustang Bio's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Mustang Bio's Pre-Tax Income falls into.
Mustang Bio Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Mustang Bio's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-51.60 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mustang Bio (NAS:MBIO) Pre-Tax Income Explanation
Mustang Bio's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mustang Bio Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Mustang Bio's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MBIO has been successfully added to your 